InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Atlas Venture Opportunity Fund I, L.P.. Officer active across 2 companies, notably Day One Biopharmaceuticals, Inc.. Aggregated, 2 filings have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €819k. History available since 1 July 2022. The latest transaction was disclosed on 1 March 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations